British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

The drugmaker plans to build a research-and-development center in Beijing and strike deals with local biotechnology companies ...

Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

BEIJING, March 30 (Xinhua) -- U.S. pharmaceutical giant Pfizer's new research and development (R&D) center officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA) on ...

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday. The investment will mark the ...

Foreign CEOs, including Tim Cook of Apple, as well as Republican Sen. Steve Daines are in Beijing for the two-day China ...